Pfizer Q3FY19: Net profit up by 51.24%; Overweight

Firstcall India Equity | Jan. 28, 2019, 12:15 p.m.

OUTLOOK AND CONCLUSION

At the current market price of Rs. 2765.60, the stock P/E ratio is at 27.61 x FY19E and 25.00 x FY20E respectively.

Earning per share (EPS) of the company for the earnings for FY19E and FY20E is seen at Rs. 100.17 and Rs. 110.62 respectively.

Operating Profit and PAT of the company are expected to grow at a CAGR of 13% each over 2017 to 2020E.

On the basis of EV/EBITDA, the stock trades at 13.72 x for FY19E and 12.20 x for FY20E.

Price to Book Value of the stock is expected to be at 4.22 x and 3.81 x for FYI19E and FY20E respectively.

Hence, we say that, we are Overweight in this particular scrip for Medium to Long term investment.



blog comments powered by Disqus